Earnings release
Page 1
BS . DASSAULT SYSTEMES Dassault Systèmes Delivers Strong Third Quarter Growth , Raises Guidance VÉLIZY - VILLACOUBLAY , France October 28 , 2021 Dassault Systèmes ( Euronext Paris : # 14003TT8 , DSY.PA ) announces IFRS unaudited financial results for the third quarter ended September 30 , 2021. The Group's Board of Directors approved these results on October 27 , 2021. This press release also includes financial information on a non - IFRS basis and reconciliations with IFRS figures in the Appendix to this communication . ● Summary Highlights ( unaudited , non - IFRS , in constant currencies ) As reported , Q321 diluted IFRS EPS increased 94.0 % to € 0.14 and non - IFRS EPS grew 40.0 % to € 0.22 Q321 total revenue rose 12 % driven by strong Licenses & Other revenue growth of 24 % YTD 3DEXPERIENCE software revenue grew 18 % with Licenses & Other revenue up 36 % YTD Cash flow from operations rose 24.5 % to € 1.25 billion ( IFRS ) Raising FY2021 Non - IFRS objectives : Revenue growth of 10 % -11 % to € 4.80- € 4.83 billion ; EPS reported growth of 25 % -27 % to € 0.94-0.95 Bernard Charlès , Dassault Systèmes ' Vice Chairman and Chief Executive Officer commented : " Virtual technology was born for sustainability : it was first used in industry for virtual prototyping , for doing things right the first time while saving materials and resources , capitalizing knowledge and know how , and improving environmental handprints . Sustainability is all about life cycle , about connecting the dots . Offering a multi - scale , multi - discipline and inclusive approach to sustainable innovation in Manufacturing Industries , Life Sciences & Healthcare and Infrastructure & Cities is possible thanks to the 3DEXPERIENCE industry solutions . In light of the COP26 challenges , the 3DEXPERIENCE platform with science - based virtual twin experience are unparalleled catalysts to rationalize our eco - bill , and ultimately reinvent a more sustainable economy . ' IFWE experience the virtual twin , we can harmonize product , nature and life ' : this is the very core of Dassault Systèmes . Earlier this month , our MEDIDATA NEXT conference drew a record number of participants . We shared significant technological advancements that will continue to position our clients at the vanguard of , among others , decentralized clinical trials , personalized therapies , and seamless connectivity between patients , site investigators and sponsors . Progressing from things to life is a core part of our strategy and mission . We believe we're entering an industry Renaissance in Life Sciences & Healthcare ; together , we have a significant opportunity to positively impact patients and drive meaningful change for Healthcare . "